Breezula Phase III Trials Begin

Update: September 13, 2023 Breezula Phase 3 Trial Enrollment Opportunities Earlier this week, someone I trust sent me a link in regards to a new androgenetic alopecia related clinical trial that is taking place in New Jersey, US. There are two very interesting keywords in the URL that I was sent: https://cenexelresearch.com/hri/trials/androgenetic-alopecia/?utm_source=Facebook&utm_medium=Paid&utm_campaign=Cassiopea%20CB-03-01%2F37&utm_content=Dermatology The shortened version … Continue reading Breezula Phase III Trials Begin

Cassiopea’s Breezula is the Real Deal

Cassiopea has just released excellent news regarding very positive interim Phase 2 results of Breezula. They now also call the product by its new chemical name of Clascoterone. Note that these are interim 6-month results and the trial is still ongoing. Update: Cassiopea stock almost doubled in the past week. This was due to their July 10 … Continue reading Cassiopea’s Breezula is the Real Deal